Dermorphin is typically administered via subcutaneous injection in medical settings, though it can also be found in research settings for experimental use. The exact dosage varies based on the individual's needs and the context of its use (e.g., pain relief vs. performance enhancement).
For clinical applications, dermorphin is generally administered in very small doses, given its potency. Typical doses range from 5 to 10 micrograms per kilogram of body weight. In the case of non-medical use or research purposes, dosage recommendations may differ, though it is essential to note that due to the peptide's powerful effects, it is crucial to exercise extreme caution.
Routes of Administration:
●Injection (Subcutaneous or Intramuscular): Dermorphin is typically administered through an injection, as this allows for quick absorption and a fast onset of action.
●Topical Application: Although less common, some research has explored topical administration of dermorphin as a means to target localized pain.
